DFV890 in addition to standard of care vs standard of care alone in COVID-19 pneumonia

Phase 2, randomised, open-label trial in coronavirus pneumonia and coronavirus disease 2019 (COVID-19) comparing DFV890 + standard of care with Standard of care alone (2 arms). Primary endpoint: APACHE II severity of disease score. Started Apr 2020; status: completed.